Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)
Recent randomized controlled multi-center trials JUPITER, CANTOS and COLCOT impressively demonstrated the effect of anti-inflammatory therapy on secondary prevention of cardiovascular events. These studies also rapidly re-vitalized the question of whether the C-reactive protein (CRP), the prototype...
Main Authors: | Myron Zaczkiewicz, Katharina Kostenzer, Matthias Graf, Benjamin Mayer, Oliver Zimmermann, Jan Torzewski |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/7/1762 |
Similar Items
-
A short review on CRP synthesis inhibition in cardiovascular disease
by: Myron Zaczkiewicz, et al.
Published: (2024-03-01) -
Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry
by: J. Torzewski, et al.
Published: (2023-12-01) -
C-reactive protein: a target for therapy to reduce inflammation
by: Salma A. Rizo-Téllez, et al.
Published: (2023-07-01) -
Usefulness of Vaspin Marker and C-reactive Protein in Assessment of the Severity of Psoriasis
by: Aya Emad Eldin Sadek, et al.
Published: (2022-01-01) -
High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)